Foley partner David Rosen, co-chair of the firm’s FDA Practice Group is speaking in the Food and Drug Law Institute’s (FDLI) webinar titled “Hatch-Waxman at 40: A Critical Examination of its Past and Future” on September 24.
This webinar will celebrate the 40th anniversary of the Hatch-Waxman Act — an influential piece of legislation that has been crucial in advancing medical innovation and making generic drugs more accessible to patients.
People
Related Insights
May 8, 2026
Foley Viewpoints
New Criteria for Tax Audits and Refunds: Greater Tax Certainty for Your Business
Recently, Mexico’s Ministry of Finance (SHCP) published the “Agreement Establishing General Criteria and Operational Guidelines of an Advisory Nature to Promote Productive Investment and Tax Compliance.” In practice, this instrument aims to foster a clear and predictable tax environment, streamline administrative procedures, encourage investment, and provide greater certainty in tax audits and refund processes. This is particularly significant in light of the upcoming review of the United States-Mexico-Canada Agreement (USMCA) and the growing interest in attracting both domestic and foreign capital to operate in Mexico.
May 8, 2026
Foley Viewpoints
DOJ Fraud Section Launches West Coast Strike Force to Target Health Care Fraud in Arizona, California, Nevada, and Other Western States
On April 30, 2026, the Department of Justice’s National Fraud Enforcement Division announced the launch of a new West Coast Strike Force, a multi-district enforcement initiative joining the Division’s Health Care Fraud Section with U.S. Attorney’s Offices for the Districts of Arizona, Nevada, and Northern California.
May 7, 2026
Foley Viewpoints
SEC Proposal to Allow Optional Semiannual Reporting for Public Companies
On May 5, 2026, the Securities and Exchange Commission (the “SEC”) proposed rule and form amendments to permit public companies to file…